This AppLovin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Benzinga01:45

ResMed Analyst Ratings

BenzingaJan 10 20:11 · Ratings

Piper Sandler Initiates ResMed(RMD.US) With Hold Rating, Announces Target Price $252

Futu NewsJan 10 18:32 · Ratings

Balanced Outlook on ResMed: Strong Execution and Innovations Offset by Valuation Concerns and Market Challenges

TipRanksJan 10 18:27

Express News | Resmed Inc : Piper Sandler Initiates Coverage With Neutral Rating; Target Price $252

BreakingsJan 10 16:38

ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025

GlobeNewswireJan 10 05:05